Target intelligence / Profile preview

Mesenteric microcirculation

Molecular classification
Other
01

Overview

The mesenteric microcirculation consists of small arteries (arterioles), capillaries, and venules within the mesentery that supply the gastrointestinal tract[1][3]. This network facilitates the exchange of gases, nutrients, waste, and immune cells between blood and intestinal tissue and is integral to maintaining intestinal and systemic homeostasis. Dysfunction of the mesenteric microcirculation, often through inflammation, ischemia, or sepsis, leads to compromised blood flow and oxygen delivery, increased leukocyte adhesion/rolling, breakdown of the endothelial barrier, and can contribute to multi-organ dysfunction or failure[1][6]. While specific molecules within this network (such as adhesion molecules or endothelial receptors) may be drug targets, "mesenteric microcirculation" as a whole is a physiological structure, not a druggable target by itself[1][3][6].

Other names
Mesenteric microvasculatureMesenteric microvesselsMesenteric capillary network
02

Mechanism of action

Improvement of microvascular perfusion (e.g., via inhibition of leukocyte adhesion, improvement of endothelial function, vasodilation)

03

Biological functions

Regulation of microvascular blood flow and resistanceExchange of oxygen, water, solutes, nutrients, and hormones between blood and tissueImmune response (regulation of leukocyte migration and inflammation)Maintenance of vascular permeabilityCapacitance (holding and releasing blood volume)
04

Disease associations

InflammationCirculatory shockIschemia-reperfusion injurySepsisMulti-organ dysfunction (as a downstream result of severe microcirculatory disturbance)
05

Safety considerations

Therapeutic targeting of the entire microcirculation is non-specific and may cause regional hypoperfusion, edema, or altered immune function, due to the fundamental physiological importance of the microvasculature in all tissues.
06

Interacting drugs

Ani HBr (Anisodamine hydrobromide)

1 more in the full profile.

07

Biomarkers

Expression of ICAM-1 and P-selectin on mesenteric endothelial cellsLeukocyte adhesion, rolling, and migration dynamics detected by intravital microscopy

Beyond the preview

Go deeper on Mesenteric microcirculation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesenteric microcirculation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call